Are you Dr. Loveless?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 69 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 N Robbins Rd
Ste 100
Boise, ID 83702Phone+1 208-383-0201Fax+1 208-489-4300- Is this information wrong?
Summary
- Dr. James Loveless, MD is a rheumatologist in Boise, Idaho. He is currently licensed to practice medicine in Idaho, Oregon, and Colorado. He is affiliated with St. Luke's Rehabilitation Hospital, St. Luke's Boise Medical Center, and Saint Alphonsus Regional Medical Center.
Education & Training
University of ColoradoFellowship, Rheumatology, 1990 - 1992- University of ColoradoResidency, Internal Medicine, 1986 - 1989
Case Western Reserve University School of MedicineClass of 1986
Certifications & Licensure
ID State Medical License 1993 - 2024
OR State Medical License 2020 - 2022
CO State Medical License 1989 - 2011
OH State Medical License 1986 - 1988- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
- A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 Apr 12
- A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Start of enrollment: 2017 May 09
Publications & Presentations
PubMed
- Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy.Keystone, E., Burmester, G. R., Furie, R., Loveless, J. E., Emery, P., Kremer, J., Tak, P. P., Broder, M. S., Yu, E., Cravets, M., Magrini, F., Jost, F.> ;Arthritis Rheum. 2008 Jun 15
- Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III ...Cohen, S. B., Emery, P., Greenwald, M. W., Dougados, M., Furie, R. A., Genovese, M. C., Keystone, E. C., Loveless, J. E., Burmester, G. R., Cravets, M. W., Hessey, E. ...> ;Arthritis Rheum. 2006 Sep
Professional Memberships
- Member
Hospital Affiliations
Saint Alphonsus Regional Medical CenterBoise, Idaho
St. Luke's Boise Medical CenterBoise, Idaho- St. Luke's Rehabilitation HospitalBoise, Idaho
